UniProt ID | CPNS1_HUMAN | |
---|---|---|
UniProt AC | P04632 | |
Protein Name | Calpain small subunit 1 | |
Gene Name | CAPNS1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 268 | |
Subcellular Localization | Cytoplasm. Cell membrane. Translocates to the plasma membrane upon calcium binding.. | |
Protein Description | Regulatory subunit of the calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction.. | |
Protein Sequence | MFLVNSFLKGGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMRILGGVISAISEAAAQYNPEPPPPRTHYSNIEANESEEVRQFRRLFAQLAGDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNIKRWQAIYKQFDTDRSGTICSSELPGAFEAAGFHLNEHLYNMIIRRYSDESGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVNIQEWLQLTMYS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Sulfoxidation | -------MFLVNSFL -------CCCCCCCC | 5.45 | 28183972 | |
1 | Acetylation | -------MFLVNSFL -------CCCCCCCC | 5.45 | 19413330 | |
6 | Phosphorylation | --MFLVNSFLKGGGG --CCCCCCCCCCCCC | 25.20 | 28355574 | |
9 | Methylation | FLVNSFLKGGGGGGG CCCCCCCCCCCCCCC | 54.20 | - | |
9 | Acetylation | FLVNSFLKGGGGGGG CCCCCCCCCCCCCCC | 54.20 | 88577 | |
9 | Sumoylation | FLVNSFLKGGGGGGG CCCCCCCCCCCCCCC | 54.20 | - | |
34 | Phosphorylation | NVLGGLISGAGGGGG HHHHHHHCCCCCCCC | 27.86 | 20068231 | |
34 | O-linked_Glycosylation | NVLGGLISGAGGGGG HHHHHHHCCCCCCCC | 27.86 | 23301498 | |
57 | Phosphorylation | GGGGGGGTAMRILGG CCCCCHHHHHHHHHH | 22.13 | 28857561 | |
57 | O-linked_Glycosylation | GGGGGGGTAMRILGG CCCCCHHHHHHHHHH | 22.13 | 23301498 | |
59 | Sulfoxidation | GGGGGTAMRILGGVI CCCHHHHHHHHHHHH | 2.48 | 28465586 | |
67 | Acetylation | RILGGVISAISEAAA HHHHHHHHHHHHHHH | 19.69 | 19608861 | |
67 | Ubiquitination | RILGGVISAISEAAA HHHHHHHHHHHHHHH | 19.69 | 19608861 | |
67 | Phosphorylation | RILGGVISAISEAAA HHHHHHHHHHHHHHH | 19.69 | 24719451 | |
70 | Phosphorylation | GGVISAISEAAAQYN HHHHHHHHHHHHHHC | 22.39 | 27251275 | |
85 | Phosphorylation | PEPPPPRTHYSNIEA CCCCCCCCCCCCCCC | 30.82 | 21945579 | |
87 | Phosphorylation | PPPPRTHYSNIEANE CCCCCCCCCCCCCCC | 11.64 | 21945579 | |
88 | Phosphorylation | PPPRTHYSNIEANES CCCCCCCCCCCCCCC | 24.59 | 21945579 | |
99 | Methylation | ANESEEVRQFRRLFA CCCCHHHHHHHHHHH | 32.95 | - | |
126 | Ubiquitination | ELMNILNKVVTRHPD HHHHHHHHHHHHCCC | 34.34 | - | |
135 | Ubiquitination | VTRHPDLKTDGFGID HHHCCCCCCCCCCHH | 52.53 | 21906983 | |
135 | Acetylation | VTRHPDLKTDGFGID HHHCCCCCCCCCCHH | 52.53 | 25953088 | |
144 | S-nitrosylation | DGFGIDTCRSMVAVM CCCCHHCCCCEEEHH | 2.41 | 2212679 | |
146 | Phosphorylation | FGIDTCRSMVAVMDS CCHHCCCCEEEHHCC | 21.54 | - | |
147 | Sulfoxidation | GIDTCRSMVAVMDSD CHHCCCCEEEHHCCC | 0.86 | 21406390 | |
151 | Sulfoxidation | CRSMVAVMDSDTTGK CCCEEEHHCCCCCCC | 2.69 | 30846556 | |
153 | Phosphorylation | SMVAVMDSDTTGKLG CEEEHHCCCCCCCCC | 20.82 | - | |
156 | Phosphorylation | AVMDSDTTGKLGFEE EHHCCCCCCCCCHHH | 36.99 | - | |
158 | Ubiquitination | MDSDTTGKLGFEEFK HCCCCCCCCCHHHHH | 43.26 | - | |
165 | Ubiquitination | KLGFEEFKYLWNNIK CCCHHHHHHHHHHHH | 42.59 | - | |
172 | Acetylation | KYLWNNIKRWQAIYK HHHHHHHHHHHHHHH | 50.10 | 25953088 | |
172 | Ubiquitination | KYLWNNIKRWQAIYK HHHHHHHHHHHHHHH | 50.10 | 21890473 | |
172 | 2-Hydroxyisobutyrylation | KYLWNNIKRWQAIYK HHHHHHHHHHHHHHH | 50.10 | - | |
178 | Phosphorylation | IKRWQAIYKQFDTDR HHHHHHHHHHHCCCC | 11.18 | 25884760 | |
179 | Acetylation | KRWQAIYKQFDTDRS HHHHHHHHHHCCCCC | 38.07 | 19608861 | |
179 | Malonylation | KRWQAIYKQFDTDRS HHHHHHHHHHCCCCC | 38.07 | 26320211 | |
179 | 2-Hydroxyisobutyrylation | KRWQAIYKQFDTDRS HHHHHHHHHHCCCCC | 38.07 | - | |
179 | Ubiquitination | KRWQAIYKQFDTDRS HHHHHHHHHHCCCCC | 38.07 | 21890473 | |
218 | Phosphorylation | NMIIRRYSDESGNMD HHHHHHHCCCCCCCC | 32.84 | 21712546 | |
224 | Sulfoxidation | YSDESGNMDFDNFIS HCCCCCCCCHHHHHH | 6.57 | 30846556 | |
244 | Acetylation | DAMFRAFKSLDKDGT HHHHHHHHCCCCCCC | 49.47 | 27452117 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CPNS1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CPNS1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CPNS1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CSPG4_HUMAN | CSPG4 | physical | 22939629 | |
TRAF5_HUMAN | TRAF5 | physical | 21988832 | |
STAT3_HUMAN | STAT3 | physical | 21988832 | |
PRGC1_HUMAN | PPARGC1A | physical | 21988832 | |
AL7A1_HUMAN | ALDH7A1 | physical | 22863883 | |
APEX1_HUMAN | APEX1 | physical | 22863883 | |
DCPS_HUMAN | DCPS | physical | 22863883 | |
ISOC1_HUMAN | ISOC1 | physical | 22863883 | |
METK2_HUMAN | MAT2A | physical | 22863883 | |
MAT2B_HUMAN | MAT2B | physical | 22863883 | |
LIS1_HUMAN | PAFAH1B1 | physical | 22863883 | |
PAK2_HUMAN | PAK2 | physical | 22863883 | |
PDIA4_HUMAN | PDIA4 | physical | 22863883 | |
PP1A_HUMAN | PPP1CA | physical | 22863883 | |
PLPHP_HUMAN | PROSC | physical | 22863883 | |
1433E_HUMAN | YWHAE | physical | 22863883 | |
1433G_HUMAN | YWHAG | physical | 22863883 | |
1433F_HUMAN | YWHAH | physical | 22863883 | |
1433T_HUMAN | YWHAQ | physical | 22863883 | |
1433Z_HUMAN | YWHAZ | physical | 22863883 | |
ATRAP_HUMAN | AGTRAP | physical | 25416956 | |
UBP1_HUMAN | USP1 | physical | 23589330 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-179, AND MASS SPECTROMETRY. |